2024 Q4 Form 10-Q Financial Statement

#000158067024000052 Filed on November 05, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $651.9M
YoY Change 5.56%
Cost Of Revenue $488.4M
YoY Change 6.46%
Gross Profit $163.5M
YoY Change 2.95%
Gross Profit Margin 25.08%
Selling, General & Admin $83.19M
YoY Change 8.7%
% of Gross Profit 50.88%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $830.0K
YoY Change 3.75%
% of Gross Profit 0.51%
Operating Expenses $83.19M
YoY Change 8.7%
Operating Profit $80.31M
YoY Change -2.4%
Interest Expense $0.00
YoY Change
% of Operating Profit 0.0%
Other Income/Expense, Net $11.55M
YoY Change 60.38%
Pretax Income $91.85M
YoY Change 2.69%
Income Tax $22.28M
% Of Pretax Income 24.25%
Net Earnings $69.58M
YoY Change 3.78%
Net Earnings / Revenue 10.67%
Basic Earnings Per Share $2.96
Diluted Earnings Per Share $2.95
COMMON SHARES
Basic Shares Outstanding 23.51M shares 23.50M shares
Diluted Shares Outstanding 23.58M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $60.90M
YoY Change 29.58%
Cash & Equivalents $60.90M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $3.394B
Prepaid Expenses
Receivables $49.02M
Other Receivables $0.00
Total Short-Term Assets $3.504B
YoY Change 15.99%
LONG-TERM ASSETS
Property, Plant & Equipment $62.00M
YoY Change 48.07%
Goodwill $12.02M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $45.74M
YoY Change -61.53%
Other Assets $42.82M
YoY Change -3.34%
Total Long-Term Assets $322.0M
YoY Change 2.47%
TOTAL ASSETS
Total Short-Term Assets $3.504B
Total Long-Term Assets $322.0M
Total Assets $3.826B
YoY Change 14.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $53.31M
YoY Change -20.78%
Accrued Expenses $134.6M
YoY Change 11.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $216.8M
YoY Change 3.28%
LONG-TERM LIABILITIES
Long-Term Debt $1.592B
YoY Change 21.61%
Other Long-Term Liabilities $19.89M
YoY Change 50.71%
Total Long-Term Liabilities $1.612B
YoY Change 21.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $216.8M
Total Long-Term Liabilities $1.612B
Total Liabilities $1.829B
YoY Change 19.35%
SHAREHOLDERS EQUITY
Retained Earnings $2.035B
YoY Change 10.74%
Common Stock $276.0K
YoY Change 0.36%
Preferred Stock
YoY Change
Treasury Stock (at cost) $373.0M
YoY Change 5.07%
Treasury Stock Shares
Shareholders Equity $1.997B
YoY Change
Total Liabilities & Shareholders Equity $3.826B
YoY Change 14.72%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $69.58M
YoY Change 3.78%
Depreciation, Depletion And Amortization $830.0K
YoY Change 3.75%
Cash From Operating Activities -$17.76M
YoY Change -84.62%
INVESTING ACTIVITIES
Capital Expenditures $64.00K
YoY Change -87.2%
Acquisitions
YoY Change
Other Investing Activities -$3.649M
YoY Change 3549.0%
Cash From Investing Activities -$3.713M
YoY Change 364.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 31.31M
YoY Change -73.91%
NET CHANGE
Cash From Operating Activities -17.76M
Cash From Investing Activities -3.713M
Cash From Financing Activities 31.31M
Net Change In Cash 9.832M
YoY Change 165.73%
FREE CASH FLOW
Cash From Operating Activities -$17.76M
Capital Expenditures $64.00K
Free Cash Flow -$17.83M
YoY Change -84.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001580670
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Trading Symbol
TradingSymbol
LGIH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23513488 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60903000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48978000 usd
CY2024Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
49022000 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
41319000 usd
CY2024Q3 us-gaap Inventory Real Estate
InventoryRealEstate
3439668000 usd
CY2023Q4 us-gaap Inventory Real Estate
InventoryRealEstate
3107648000 usd
CY2024Q3 us-gaap Earnest Money Deposits
EarnestMoneyDeposits
33676000 usd
CY2023Q4 us-gaap Earnest Money Deposits
EarnestMoneyDeposits
30354000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
62001000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45522000 usd
CY2024Q3 us-gaap Other Assets
OtherAssets
159399000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
113849000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9146000 usd
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
373022000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1996963000 usd
CY2024Q3 us-gaap Revenues
Revenues
651854000 usd
CY2023Q3 us-gaap Revenues
Revenues
617539000 usd
us-gaap Revenues
Revenues
1645202000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
488362000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
458734000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1239425000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
80305000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
82276000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
166559000 usd
CY2024Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
11547000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
91852000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
89449000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
191829000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22277000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22407000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
46628000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
69575000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
67042000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.96
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.85
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.17
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.95
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.84
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.15
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23500349 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23546061 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23540620 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23579592 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23640686 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23611906 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1642412000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
26962000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3103000 usd
dei Entity Registrant Name
EntityRegistrantName
LGI HOMES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
8163000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
12018000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
12018000 usd
CY2024Q3 us-gaap Assets
Assets
3825833000 usd
CY2023Q4 us-gaap Assets
Assets
3407851000 usd
CY2024Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
53314000 usd
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
31616000 usd
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
229097000 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
271872000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Selling Expense
SellingExpense
55196000 usd
CY2023Q3 us-gaap Selling Expense
SellingExpense
49781000 usd
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
7173000 usd
us-gaap Net Income Loss
NetIncomeLoss
145201000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2360000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1289000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1731012000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
67042000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3123000 usd
us-gaap Net Income Loss
NetIncomeLoss
147138000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
8493000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
9989000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1780000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
10750000 usd
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
6450000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
4200000 usd
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
13000000 usd
us-gaap Selling Expense
SellingExpense
149196000 usd
us-gaap Selling Expense
SellingExpense
141811000 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
25270000 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
19793000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
193206000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1996963000 usd
dei Entity Address Address Line1
EntityAddressAddressLine1
1450 Lake Robbins Drive,
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 430,
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77380
dei City Area Code
CityAreaCode
(281)
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 us-gaap Notes Payable
NotesPayable
1546459000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
1248332000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
1828870000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1551820000 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4112462 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3939472 shares
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
355022000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1856031000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3825833000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3407851000 usd
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
us-gaap Revenues
Revenues
1750166000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1350608000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
173413000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
46068000 usd
us-gaap Net Income Loss
NetIncomeLoss
147138000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.21
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23562374 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23696095 shares
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1856031000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
17053000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
786000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10002000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3829000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1506000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1869203000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
58573000 usd
CY2024Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
7998000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2841000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1223000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1923842000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1546000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1674229000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
53134000 usd
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3088013
dei Entity Address City Or Town
EntityAddressCityOrTown
The Woodlands,
dei Local Phone Number
LocalPhoneNumber
362-8998
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27625950 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23513488 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27521120 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23581648 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
276000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
275000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
334792000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
321062000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2034917000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1889716000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27991000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26748000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
90022000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
84334000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
69575000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
69575000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2256000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1290000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
206000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1498000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1802675000 usd
us-gaap Net Income Loss
NetIncomeLoss
145201000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9612000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
10737000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2280000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1634000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
8926000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
8586000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
983000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
3438000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7703000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10508000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
390896000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
194360000 usd
us-gaap Increase Decrease In Earnest Money Deposits Outstanding
IncreaseDecreaseInEarnestMoneyDepositsOutstanding
3322000 usd
us-gaap Increase Decrease In Earnest Money Deposits Outstanding
IncreaseDecreaseInEarnestMoneyDepositsOutstanding
9630000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
670000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-30873000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
21698000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
42002000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
23597000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-34980000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-200747000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22675000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1345000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
848000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
5296000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
11619000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
0 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
4871000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6641000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7596000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
507666000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
335864000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
214000000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
260000000 usd
lgih Proceeds From Land Financing Arrangements
ProceedsFromLandFinancingArrangements
0 usd
CY2023 lgih Proceeds From Land Financing Arrangements
ProceedsFromLandFinancingArrangements
50402000 usd
lgih Payments On Financing Arrangements
PaymentsOnFinancingArrangements
60274000 usd
CY2023 lgih Payments On Financing Arrangements
PaymentsOnFinancingArrangements
79784000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
97000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
5561000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4018000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4333000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
18000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
219313000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45254000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11925000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14983000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48978000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31998000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60903000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46981000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates, and these differences could have a significant impact on the financial statements.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which is intended to enhance the transparency and decision usefulness of income tax disclosures. This amendment modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold, (2) the amount of income taxes paid (net of refunds received) (disaggregated by federal, state, and foreign taxes) as well as individual jurisdictions in which income taxes paid is equal to or greater than 5 percent of total income taxes paid net of refunds, (3) the income or loss from continuing operations before income tax expense or benefit (disaggregated between domestic and foreign) and (4) income tax expense or benefit from continuing operations (disaggregated by federal, state and foreign). The guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, while retrospective application is permitted. We are currently evaluating the impact that this standard will have on our financial statements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”), which is intended to improve reportable segment disclosure requirements, primarily through additional and more detailed information about a reportable segment’s expenses. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The guidance is to be applied retrospectively to all prior periods presented in the financial statements. Upon transition, the segment expense categories and amounts disclosed in the prior periods should be based on the significant segment expense categories identified and disclosed in the period of adoption. We are currently evaluating the impact that this standard will have on our financial statements.</span></div>
CY2024Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
2244256000 usd
CY2023Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
2099133000 usd
CY2024Q3 us-gaap Inventory Operative Builders Other
InventoryOperativeBuildersOther
55446000 usd
CY2023Q4 us-gaap Inventory Operative Builders Other
InventoryOperativeBuildersOther
47936000 usd
CY2024Q3 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
469280000 usd
CY2023Q4 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
313124000 usd
CY2024Q3 us-gaap Inventory Finished Homes
InventoryFinishedHomes
624951000 usd
CY2023Q4 us-gaap Inventory Finished Homes
InventoryFinishedHomes
542996000 usd
CY2024Q3 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
3393933000 usd
CY2023Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
3003189000 usd
CY2024Q3 lgih Inventory Real Estate Not Owned
InventoryRealEstateNotOwned
45735000 usd
CY2023Q4 lgih Inventory Real Estate Not Owned
InventoryRealEstateNotOwned
104459000 usd
CY2024Q3 us-gaap Inventory Real Estate
InventoryRealEstate
3439668000 usd
CY2023Q4 us-gaap Inventory Real Estate
InventoryRealEstate
3107648000 usd
lgih Transfer Of Real Estate Inventory To Rental Properties
TransferOfRealEstateInventoryToRentalProperties
17400000 usd
CY2024Q3 lgih Real Estate Inventory Development And Construction Payable
RealEstateInventoryDevelopmentAndConstructionPayable
66060000 usd
CY2023Q4 lgih Real Estate Inventory Development And Construction Payable
RealEstateInventoryDevelopmentAndConstructionPayable
71193000 usd
CY2024Q3 lgih Land Financing Arrangements
LandFinancingArrangements
45735000 usd
CY2023Q4 lgih Land Financing Arrangements
LandFinancingArrangements
104459000 usd
CY2024Q3 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
28904000 usd
CY2023Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
14694000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
16927000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
22550000 usd
CY2024Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
15650000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
13600000 usd
CY2024Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
18238000 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
13522000 usd
CY2024Q3 lgih Inventory Related Obligations
InventoryRelatedObligations
11540000 usd
CY2023Q4 lgih Inventory Related Obligations
InventoryRelatedObligations
11924000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
6149000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4947000 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4994000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2909000 usd
CY2024Q3 us-gaap Other Liabilities
OtherLiabilities
14900000 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
12074000 usd
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
229097000 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
271872000 usd
lgih Inventory Related Obligation Term
InventoryRelatedObligationTerm
P30Y
CY2024Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
14700000 usd
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
12150000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
13600000 usd
CY2024Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2020000 usd
CY2023Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2220000 usd
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
5977000 usd
CY2024Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1070000 usd
CY2023Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1370000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3927000 usd
CY2024Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
15650000 usd
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
13000000 usd
CY2024Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
15650000 usd
us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0185
CY2024Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
16840000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
21301000 usd
CY2024Q3 us-gaap Notes Payable
NotesPayable
1546459000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
1248332000 usd
CY2024Q3 us-gaap Interest Costs Incurred
InterestCostsIncurred
30544000 usd
CY2023Q3 us-gaap Interest Costs Incurred
InterestCostsIncurred
21578000 usd
us-gaap Interest Costs Incurred
InterestCostsIncurred
89130000 usd
us-gaap Interest Costs Incurred
InterestCostsIncurred
62865000 usd
CY2024Q3 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
30544000 usd
CY2023Q3 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
21578000 usd
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
89130000 usd
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
62865000 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
0 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Interest Expense
InterestExpense
0 usd
CY2024Q3 us-gaap Interest Paid
InterestPaid
23110000 usd
CY2023Q3 us-gaap Interest Paid
InterestPaid
23358000 usd
us-gaap Interest Paid
InterestPaid
79925000 usd
us-gaap Interest Paid
InterestPaid
63114000 usd
CY2024Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3100000 usd
CY2023Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2400000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
11500000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
10600000 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.243
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.243
CY2024Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
5200000 usd
CY2023Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
20200000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
33500000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
80000000.0 usd
CY2022Q1 lgih Stock Repurchase Program Additional Amount Authorized
StockRepurchaseProgramAdditionalAmountAuthorized
200000000.0 usd
CY2022Q1 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
550000000.0 usd
CY2024Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
172990 shares
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
18000000.0 usd
CY2023Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
3112462 shares
CY2024Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
193500000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
69575000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
67042000 usd
us-gaap Net Income Loss
NetIncomeLoss
145201000 usd
us-gaap Net Income Loss
NetIncomeLoss
147138000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23500349 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23546061 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23540620 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23562374 shares
CY2024Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
79243 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
94625 shares
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
71286 shares
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
133721 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23579592 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23640686 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23611906 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23696095 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.96
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.85
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.24
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.95
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.84
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.21
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3069 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1749 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10025 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4735 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
1
CY2024Q3 us-gaap Land Under Purchase Options Recorded
LandUnderPurchaseOptionsRecorded
29290000 usd
CY2023Q4 us-gaap Land Under Purchase Options Recorded
LandUnderPurchaseOptionsRecorded
26955000 usd
CY2024Q3 lgih Commitment Under Land Purchase Option And Deposit Agreement
CommitmentUnderLandPurchaseOptionAndDepositAgreement
587325000 usd
CY2023Q4 lgih Commitment Under Land Purchase Option And Deposit Agreement
CommitmentUnderLandPurchaseOptionAndDepositAgreement
513941000 usd
CY2024Q3 lgih Lots Under Purchase Options Recorded
LotsUnderPurchaseOptionsRecorded
14535
CY2023Q4 lgih Lots Under Purchase Options Recorded
LotsUnderPurchaseOptionsRecorded
15750
CY2024Q3 lgih Refundable Land Deposits Of Purchase Contractsof Finished Lots
RefundableLandDepositsOfPurchaseContractsofFinishedLots
11900000 usd
CY2023Q4 lgih Refundable Land Deposits Of Purchase Contractsof Finished Lots
RefundableLandDepositsOfPurchaseContractsofFinishedLots
11400000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5700000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4600000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
6100000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4900000 usd
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
600000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
700000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
1800000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
1900000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1400000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1400000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.059
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
462000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1829000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1602000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1389000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
970000 usd
CY2024Q3 lgih Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
709000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6961000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
812000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
6149000 usd
CY2024Q3 lgih Lettersof Credit Surety Bondsand Other Financial Guarantees
LettersofCreditSuretyBondsandOtherFinancialGuarantees
376300000 usd
CY2023Q4 lgih Lettersof Credit Surety Bondsand Other Financial Guarantees
LettersofCreditSuretyBondsandOtherFinancialGuarantees
357000000.0 usd
us-gaap Payments To Acquire Limited Partnership Interests
PaymentsToAcquireLimitedPartnershipInterests
25500000 usd
CY2023 us-gaap Payments To Acquire Limited Partnership Interests
PaymentsToAcquireLimitedPartnershipInterests
21500000 usd
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4600000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9600000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3200000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
8500000 usd
CY2024Q3 us-gaap Revenues
Revenues
651854000 usd
CY2023Q3 us-gaap Revenues
Revenues
617539000 usd
us-gaap Revenues
Revenues
1645202000 usd
us-gaap Revenues
Revenues
1750166000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
7 business
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
5 home
CY2024Q3 us-gaap Revenues
Revenues
651854000 usd
CY2023Q3 us-gaap Revenues
Revenues
617539000 usd
us-gaap Revenues
Revenues
1645202000 usd
us-gaap Revenues
Revenues
1750166000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
91852000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
89449000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
191829000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
193206000 usd
CY2024Q3 us-gaap Assets
Assets
3825833000 usd
CY2023Q4 us-gaap Assets
Assets
3407851000 usd
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001580670-24-000052-index-headers.html Edgar Link pending
0001580670-24-000052-index.html Edgar Link pending
0001580670-24-000052.txt Edgar Link pending
0001580670-24-000052-xbrl.zip Edgar Link pending
a93024ex311.htm Edgar Link pending
a93024ex312.htm Edgar Link pending
a93024ex321.htm Edgar Link pending
a93024ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lgih-20240930.htm Edgar Link pending
lgih-20240930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
lgih-20240930_cal.xml Edgar Link unprocessable
lgih-20240930_def.xml Edgar Link unprocessable
lgih-20240930_lab.xml Edgar Link unprocessable
lgih-20240930_pre.xml Edgar Link unprocessable
lgih-20240930_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable